Ein guter Preis.  Online

Einzelheiten zu den Produkten

Created with Pixso. Zu Hause Created with Pixso. Produits Created with Pixso.
Brust-Lungenkrebs-Medikamente
Created with Pixso. Dacomitinib Tablets 15mg 30 Tablets Box Second Generation Irreversible Pan HER EGFR TKI for EGFR Mutant Advanced NSCLC

Dacomitinib Tablets 15mg 30 Tablets Box Second Generation Irreversible Pan HER EGFR TKI for EGFR Mutant Advanced NSCLC

Markenname: Sichuan Kelun Pharmaceutical Co., Ltd.
Modellnummer: Dacomitinib KL-20254254
Mindestbestellmenge: Verhandelbar
Preis: Please contact a specialist WhatsApp:55342706
Lieferzeit: Verhandelbar
Zahlungsbedingungen: Western Union, MoneyGram, T/T.
Detailinformationen
Herkunftsort:
Chengdu, Sichuan, China
Zertifizierung:
NMPA/GMP
Verpackung Informationen:
Verhandelbar
Versorgungsmaterial-Fähigkeit:
Verhandelbar
Hervorheben:

Irreversible Pan HER EGFR TKI

,

Second Gen EGFR Mutant NSCLC

,

Covalent EGFR HER2 HER4 Inhibitor

Produktbeschreibung
Dacomitinib 15mg x 30 Tablets [Product Name] Generic Name: Dacomitinib Specification: 15mg x 30 Tablets [Active Ingredient] Dacomitinib [Indications] First-line EGFR exon 19 del or L858R NSCLC. 15mg: second dose-reduction level from 45mg starting dose. [Mechanism of Action] Second-gen irreversible covalent ErbB family (EGFR/HER2/HER4) inhibitor. ARCHER 1050: superior OS vs gefitinib in first-line EGFR-mutant NSCLC. [Dosage] Starting dose: 45mg daily. Reduce to 30mg then 15mg